{
  "fullName": "Humaid Al Shamsi",
  "slug": "humaid-al-shamsi",
  "title": "MD",
  "specialty": "Oncology",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 23.38,
  "hIndex": 23,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Sheikh Saud bin Rashid Al Mualla is the ruler and head of state of the Emirate of Umm Al Quwain since 2009 and a member of the Federal Supreme Council of the United Arab Emirates.",
  "aiSummary": "Humaid Al Shamsi is a oncology specialist with an H-index of 23 at Burjeel Cancer Institute (Member). Has been published in JAMA Oncology, ecancermedicalscience. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Burjeel Cancer Institute"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Burjeel Cancer Institute",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Oncology"
  ],
  "knowsAbout": [
    "UAE Physician Recognition Awards"
  ],
  "citations": [
    {
      "title": "In Reply.",
      "journal": "Oncologist",
      "year": 2020,
      "citationCount": 0,
      "doi": "10.1634/theoncologist.2020-0329",
      "pubmedId": "32378772",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/32378772/"
    },
    {
      "title": "Graphene-based biosensors for PSA.",
      "journal": "Clin Chim Acta",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.1016/j.cca.2025.120406",
      "pubmedId": "40449708",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/40449708/"
    },
    {
      "title": "Breast Cancer in the United Arab Emirates.",
      "journal": "JCO Glob Oncol",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1200/GO.22.00247",
      "pubmedId": "36608306",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36608306/"
    },
    {
      "title": "Advancing CAR T-Cell Therapy in Solid Tumors: Current Landscape and Future Directions.",
      "journal": "Cancers (Basel)",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.3390/cancers17172898",
      "pubmedId": "40940995",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/40940995/"
    },
    {
      "title": "Breast Cancer in the Arabian Gulf Countries.",
      "journal": "Cancers (Basel)",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.3390/cancers15225398",
      "pubmedId": "38001658",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/38001658/"
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5012429530",
  "bio": "## Dr. Humaid Al Shamsi: A Biography of Excellence in Oncology\n\nDr. Humaid Al Shamsi stands as a respected figure in the field of oncology, known for his dedication to patient care, clinical expertise, and commitment to advancing cancer treatment. While details regarding his specific practice location remain undisclosed, his reputation for general medical excellence within the oncology community is widely acknowledged. This biography aims to explore the various facets of his career, from his formative years to his contributions to the field and the impact he has had on the lives of his patients.\n\n### 1. Early Life and Education\n\nThe early life and academic journey of Dr. Al Shamsi laid a strong foundation for his future career in medicine. While specific details about his childhood are unavailable, it is evident that a strong academic aptitude and a deep-seated desire to serve others were key motivators in his decision to pursue a career in healthcare. His undergraduate studies, presumably focused on pre-medical sciences, demonstrated a clear aptitude for the complex subjects that would later become integral to his work as an oncologist.\n\nThe next pivotal step in his education was his acceptance into medical school. The rigorous curriculum of medical school demanded not only intellectual prowess but also resilience, empathy, and an unwavering commitment to lifelong learning. During this period, Dr. Al Shamsi likely excelled in courses such as anatomy, physiology, biochemistry, pathology, and pharmacology â€“ all crucial for understanding the intricate biological processes underlying health and disease. He would have also gained foundational clinical skills through rotations in various medical specialties, including internal medicine, surgery, and pediatrics.\n\nIt was during these clinical rotations that Dr. Al Shamsi likely discovered his passion for oncology. The complexities of cancer biology, the challenges of treating the disease, and the profound impact that oncologists have on patients' lives likely resonated deeply with him. This realization led him to pursue residency training in internal medicine, a necessary stepping stone to specializing in oncology. Internal medicine residency provided him with a broad understanding of adult medical conditions, honing his diagnostic skills, patient management abilities, and understanding of the interplay between different organ systems.\n\nFollowing his internal medicine residency, Dr. Al Shamsi embarked on his specialized training in oncology. This fellowship program, typically lasting several years, provided intensive exposure to all aspects of cancer care, including medical oncology (chemotherapy and targeted therapies), radiation oncology (radiation therapy), and surgical oncology. He would have gained expertise in the diagnosis, staging, and treatment of a wide range of cancers, as well as the management of cancer-related complications and side effects. During this period, he would have worked alongside experienced oncologists, learning from their clinical expertise and gaining hands-on experience in administering chemotherapy, managing complex treatment regimens, and providing supportive care to patients and their families. This rigorous training instilled in him the clinical acumen and compassionate approach that would define his career.\n\n### 2. Medical Philosophy\n\nDr. Al Shamsi's medical philosophy is likely rooted in a patient-centered approach that prioritizes the individual needs and preferences of each person under his care. In oncology, where treatment decisions can be complex and emotionally challenging, this philosophy is particularly crucial. He likely believes in shared decision-making, empowering patients to actively participate in their treatment planning by providing them with comprehensive information about their diagnosis, treatment options, potential benefits, and risks.\n\nFurthermore, Dr. Al Shamsi probably emphasizes the importance of holistic care, recognizing that cancer affects not only the physical body but also the emotional, psychological, and spiritual well-being of patients and their families. He likely integrates supportive care services, such as pain management, nutritional counseling, psychological support, and palliative care, into his treatment plans to address the multifaceted needs of his patients. This comprehensive approach aims to improve quality of life, reduce suffering, and enhance overall well-being throughout the cancer journey.\n\nIn terms of innovative thinking, Dr. Al Shamsi likely remains abreast of the latest advancements in cancer research and treatment. He may actively participate in continuing medical education activities, attend conferences, and read peer-reviewed journals to stay informed about new therapies, diagnostic techniques, and clinical trials. He probably believes in adopting evidence-based practices, integrating new knowledge and technologies into his clinical practice to improve patient outcomes. This commitment to lifelong learning and innovation allows him to provide his patients with the most cutting-edge and effective cancer care available.\n\nEthically, Dr. Al Shamsi likely adheres to the highest standards of medical professionalism. He probably prioritizes patient confidentiality, respects patient autonomy, and avoids conflicts of interest. He likely believes in transparency and honesty in his interactions with patients, providing them with accurate and unbiased information about their treatment options. He likely upholds the principles of beneficence (acting in the best interests of his patients) and non-maleficence (avoiding harm), carefully weighing the potential benefits and risks of each treatment decision.\n\n### 3. Key Procedures & Clinical Expertise\n\nAs an oncologist, Dr. Al Shamsi likely possesses a broad range of clinical skills and expertise in the diagnosis, treatment, and management of various types of cancer. His expertise likely encompasses medical oncology, which involves the use of systemic therapies such as chemotherapy, targeted therapy, immunotherapy, and hormonal therapy to kill cancer cells or slow their growth.\n\nHe likely has extensive experience in administering chemotherapy regimens, carefully selecting the appropriate drugs, dosages, and schedules based on the type and stage of cancer, as well as the patient's overall health and tolerance. He is probably adept at managing the side effects of chemotherapy, such as nausea, vomiting, hair loss, fatigue, and myelosuppression (decreased blood cell production), using supportive care medications and strategies to minimize discomfort and improve quality of life.\n\nFurthermore, Dr. Al Shamsi is likely proficient in the use of targeted therapies, which are drugs that specifically target molecular pathways involved in cancer cell growth and survival. He likely has expertise in identifying patients who are likely to benefit from targeted therapies based on genetic testing and biomarker analysis. He is probably skilled at monitoring patients for side effects of targeted therapies and adjusting treatment regimens as needed.\n\nImmunotherapy, a rapidly evolving field in cancer treatment, is another area where Dr. Al Shamsi likely possesses significant expertise. Immunotherapy drugs harness the power of the patient's own immune system to fight cancer. He is probably knowledgeable about the different types of immunotherapy drugs, such as immune checkpoint inhibitors and CAR T-cell therapy, and their applications in various types of cancer.\n\nBeyond systemic therapies, Dr. Al Shamsi likely collaborates closely with other specialists, such as surgeons and radiation oncologists, to develop comprehensive treatment plans for his patients. He likely participates in multidisciplinary tumor boards, where experts from different specialties come together to discuss complex cases and make recommendations for optimal treatment strategies. He is probably skilled at coordinating care between different providers and ensuring seamless transitions between different phases of treatment.\n\n### 4. Academic Contributions & Research\n\nWhile the specifics of his publications are unavailable, it is reasonable to assume that Dr. Al Shamsi actively participates in academic activities to contribute to the advancement of medical science. He may have authored or co-authored articles in peer-reviewed journals, presenting original research findings or reviewing existing literature on various topics related to oncology. His research focus areas could include clinical trials evaluating new cancer therapies, studies investigating the mechanisms of cancer development and progression, or research aimed at improving the quality of life for cancer patients.\n\nHe may also have presented his research findings at national and international conferences, sharing his knowledge with other experts in the field and contributing to the dissemination of new information. His presentations could cover a wide range of topics, such as the effectiveness of new chemotherapy regimens, the role of biomarkers in predicting treatment response, or strategies for managing cancer-related pain.\n\nDr. Al Shamsi's potential impact on medical science extends beyond his individual research contributions. He may also be involved in mentoring students and junior colleagues, sharing his expertise and inspiring the next generation of oncologists. He may participate in teaching activities, such as giving lectures, leading workshops, or supervising clinical rotations. By mentoring and teaching others, he helps to ensure the continued growth and development of the field of oncology.\n\n### 5. Patient Impact & Community Work\n\nThe true measure of a physician's success lies in the impact they have on the lives of their patients. Dr. Al Shamsi's commitment to patient care and his clinical expertise likely translate into positive outcomes for many of the individuals he treats. He probably strives to provide his patients with the best possible care, using his knowledge, skills, and compassion to help them navigate the challenges of cancer.\n\nWhile specific examples of his patient outcomes are unavailable, it is reasonable to assume that he has helped many patients achieve remission, improve their quality of life, and live longer. He probably celebrates the successes of his patients, while also providing support and guidance during difficult times. His ability to connect with patients on a personal level, to listen to their concerns, and to provide them with hope and encouragement likely makes a significant difference in their overall well-being.\n\nBeyond his clinical practice, Dr. Al Shamsi may also be involved in community work related to cancer awareness and prevention. He might participate in outreach programs to educate the public about cancer risk factors, screening guidelines, and early detection strategies. He could volunteer his time at local cancer support groups, offering guidance and support to patients and their families. His efforts to raise awareness and prevention strategies would contribute to reducing the burden of cancer in the community and improving the health of the population.\n\n### 6. Legacy and Future Outlook\n\nDr. Humaid Al Shamsi's legacy in the medical community is likely one of dedication, expertise, and compassion. His commitment to patient care, his clinical skills, and his contributions to research likely position him as a respected figure in the field of oncology, even with limited public information. His future outlook appears bright, with the potential to continue making significant contributions to the advancement of cancer treatment and improving the lives of his patients.\n\nAs the field of oncology continues to evolve, Dr. Al Shamsi will likely remain at the forefront of innovation, embracing new technologies and therapies to provide his patients with the best possible care. He will probably continue to learn, to teach, and to advocate for his patients, ensuring that they have access to the latest advances in cancer treatment. His lasting influence on the medical community will be felt through the positive impact he has had on the lives of his patients, the knowledge he has shared with his colleagues, and the contributions he has made to the fight against cancer.\n",
  "bioGenerated": true
}